Chimeric Therapeutics
  1. Companies
  2. Chimeric Therapeutics
  3. Products
  4. Chimeric - Model CHM 3301 (Undisclosed ...

ChimericModel CHM 3301 (Undisclosed CAR NK) -NK Cell Derived Allogeneic Therapies

SHARE

CHM 3301 (Undisclosed CAR NK) will be developed on the next generation CORE-NK platform leveraging a currently undisclosed Chimeric Antigen Receptor.